ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,237, issued on Sept. 15, was assigned to INNOVENT BIOLOGICS (SUZHOU) Co. LTD. (Suzhou, China).
"Formulation comprising anti-IL-23P19 antibody, method for preparing same and use thereof" was invented by Wei Cao (Suzhou, China), Liqiang Ma (Suzhou, China), Yinjue Wang (Suzhou, China) and Kaisong Zhou (Suzhou, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a formulation comprising an anti-IL-23p19 antibody, and in particular to a pharmaceutical formulation comprising an anti-IL-23p19 antibody, a buffer, a stabilizer and a surfactant. Furthermore, the present invention further relates to therapeutic or prophylacti...